Literature DB >> 32699269

Upadacitinib in MTX-naive RA.

Sarah Onuora1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32699269     DOI： 10.1038/s41584-020-0479-0

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  1 in total

1.  Efficacy and Safety of Upadacitinib Monotherapy in Methotrexate-Naive Patients With Moderately-to-Severely Active Rheumatoid Arthritis (SELECT-EARLY): A Multicenter, Multi-Country, Randomized, Double-Blind, Active Comparator-Controlled Trial.

Authors:  Ronald van Vollenhoven; Tsutomu Takeuchi; Aileen L Pangan; Alan Friedman; Mohamed-Eslam F Mohamed; Su Chen; Maureen Rischmueller; Ricardo Blanco; Ricardo M Xavier; Vibeke Strand
Journal:  Arthritis Rheumatol       Date:  2020-09-08       Impact factor: 10.995
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.